Latest Recruitment News

WasteCo Group’s Chair Roger Gower will resign in July 2026, with Sean Joyce stepping up as Chair amid ongoing CEO recruitment and operational upgrades.

Recce Pharmaceuticals has secured ethics approval to upgrade and broaden its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, accelerating recruitment and reinforcing its global registration ambitions.

Emyria has trained its first cohort of 31 clinicians in New South Wales, paving the way for its inaugural Sydney Empax clinic at Matilda Nepean, scheduled to open in Q3 2026.

Altair Minerals has strengthened its exploration leadership by appointing Dr. Sonia Scarselli as Specialist Advisor and forming a joint Technical Committee with Endeavour Mining to accelerate its Greater Oko Project in Guyana.

Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial has passed a third independent safety review, endorsing continuation without changes. Final topline efficacy data is expected in November 2026.

Regener8 Resources is transitioning its leadership as founder Stephen Foley steps down, paving the way for a new Managing Director with regional operational expertise to steer the company’s next exploration phase in Bosnia and Herzegovina.

Flight Centre Travel Group has trimmed its FY26 profit forecast due to Middle East conflict impacts on leisure travel, while launching a fresh $200 million share buy-back reflecting confidence in recovery.

Sierra Nevada Gold (ASX: SNX) reports 60% completion of its Phase 1 drilling at the As Safra copper-gold project in Saudi Arabia, with promising geological signs and ongoing government backing.

EDU Holdings lifted total student enrolments by 32% in Trimester 2 2026, driven by strong growth at its higher education arm Ikon Institute, offsetting softness in its vocational training division.

Neurizon Therapeutics has dosed over 50% of participants in the HEALEY ALS Platform Trial's Regimen I, exceeding recruitment expectations after expanding the cohort from 160 to 240 patients. The accelerated pace puts the company on track for last patient dosing in Q2 2027 and topline results by early Q3 2027.

Vault Minerals has submitted a fully certified Closure Plan Amendment for its Southern Tailings Management Facility, marking a regulatory milestone that supports a planned restart of underground development in Q1 FY27 and gold production in Q1 FY28 at Sugar Zone, Ontario.

Emyria Limited is progressing its national network of psychedelic-assisted therapy clinics, reporting durable patient outcomes, expanding funding sources, and benefiting from regulatory changes that broaden therapist eligibility.